RECURRENT INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for RECURRENT INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo enters early trial for Tough-to-Treat digestive cancers
Disease control OngoingThis early-stage study is testing a combination of two drugs, guadecitabine and durvalumab, in people with advanced cancers of the liver, pancreas, bile duct, or gallbladder that have spread. The main goals are to find the safest dose and see what side effects occur. Researchers …
Matched conditions: RECURRENT INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for Tough-to-Treat bile duct cancers
Disease control OngoingThis study is for people with advanced bile duct, gallbladder, or liver bile duct cancer that has worsened after initial treatment. It tests whether adding a targeted pill called binimetinib to standard chemotherapy (FOLFOX) helps patients live longer and better control the cance…
Matched conditions: RECURRENT INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC